Transforming medical devices for improved patient outcomes

Micell has engaged in several preclinical and clinical trials to determine the efficacy and safety of its MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (SES). View our preclinical trials or our clinical trials. Please see our data presentations and publications for more detailed information on results.